The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice.

Molly S CroweCatheryn D WilsonEmma LeishmanPaul L PratherHeather B BradshawMatthew L Banks Steven G Kinsey

Published in: British journal of pharmacology (2017)

These data support the strategy of combining MAGL inhibition with a commonly prescribed analgesic as a therapeutic approach for attenuating neuropathic pain.

Keyphrases

neuropathic pain
spinal cord
spinal cord injury
electronic health record
high fat diet induced
pain management
big data
ultrasound guided
postoperative pain
type diabetes
wild type
insulin resistance
skeletal muscle
data analysis
chronic pain
metabolic syndrome
artificial intelligence
deep learning
anti inflammatory